The Sensex has tumbled 8% from its September peak due to global and domestic pressures, but major brokerages remain cautiously optimistic about India’s long-term growth prospects. HSBC, Goldman Sachs, Citi, and CLSA highlight opportunities in sectors like financials, infrastructure, and IT, while advising caution amid high valuations and FII outflows.
Market in consolidation mode; triggers needed, says Sunil Subramaniam
Indian pharma stocks are rebounding, driven by domestic investors after a period of Foreign Institutional Investor (FII) selling pressure. Uncertainty surrounding potential US tariffs, fueled
July 28, 2025